Modular retro-vectors for transgenic and therapeutic use

Fauzia Solaiman, Mary Ann Zink, Guoping Xu, James Grunkemeyer, Dominic Cosgrove, Jennifer Saenz, Clague P. Hodgson

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Retroviruses have been used for many years as vectors for human gene therapy as well as for making transgenic animals. However, the efficient insertion of genes by retroviruses is often complicated by transcriptional inactivation of the retroviral long terminal repeats (LTRs) and by the production of replication-competent retroviruses (RCR). Solutions to these and other difficulties are being found in modular vectors, in which the desirable features of different vector systems are combined. Examples of synergistic vectors include virosomes (liposome/virus delivery), adeno-retro vectors, and MLV/VL30 chimeras. As gene delivery systems become increasingly complex, methodology is also needed for precise assembly of modular vectors. Gene self-assembly (GENSA) technology permits seamless vector construction and simultaneous, multifragment assembly. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)309-315
Number of pages7
JournalMolecular Reproduction and Development
Volume56
Issue number2 SUPPL.
DOIs
StatePublished - 2000

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Modular retro-vectors for transgenic and therapeutic use'. Together they form a unique fingerprint.

  • Cite this